home / stock / cmta / cmta quote
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $26.35 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $N/A | $26.35 | $N/A | $N/A | 0 | 04-22-2019 |
$ | $N/A | $26.35 | $N/A | $N/A | 0 | 04-19-2019 |
$ | $N/A | $26.35 | $N/A | $N/A | 0 | 04-18-2019 |
$ | $26.51 | $26.35 | $26.69 | $26.28 | 716,706 | 04-17-2019 |
$ | $26.30 | $26.38 | $26.50 | $26.25 | 114,119 | 04-16-2019 |
$ | $26.73 | $26.32 | $26.73 | $26.18 | 594,214 | 04-15-2019 |
$ | $26.374 | $26.49 | $26.50 | $26.35 | 118,470 | 04-12-2019 |
$ | $26.50 | $26.40 | $26.55 | $26.27 | 588,186 | 04-11-2019 |
$ | $26.34 | $26.48 | $26.53 | $26.34 | 160,498 | 04-10-2019 |
$ | $26.07 | $26.28 | $26.34 | $26.05 | 53,015 | 04-09-2019 |
$ | $25.96 | $26.09 | $26.30 | $25.93 | 206,393 | 04-08-2019 |
$ | $26.00 | $25.95 | $26.015 | $25.86 | 125,067 | 04-05-2019 |
$ | $26.01 | $25.98 | $26.07 | $25.90 | 246,278 | 04-04-2019 |
$ | $26.12 | $25.96 | $26.15 | $25.96 | 43,355 | 04-03-2019 |
$ | $26.15 | $26.07 | $26.15 | $25.95 | 101,133 | 04-02-2019 |
$ | $26.17 | $26.11 | $26.585 | $26.02 | 33,626 | 04-01-2019 |
$ | $26.05 | $26.10 | $26.36 | $26.00 | 37,167 | 03-29-2019 |
$ | $26.00 | $26.00 | $26.00 | $25.94 | 25,696 | 03-28-2019 |
$ | $26.05 | $25.97 | $26.05 | $25.92 | 39,925 | 03-27-2019 |
$ | $25.91 | $25.98 | $26.00 | $25.91 | 42,828 | 03-26-2019 |
News, Short Squeeze, Breakout and More Instantly...
Clementia Pharmaceuticals Inc. Company Name:
CMTA Stock Symbol:
NASDAQ Market:
Clementia Pharmaceuticals Inc. Website:
TORONTO, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”),...
MONTREAL, April 11, 2019 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA) ("Clementia" or the "Corporation") is pleased to announce that the Québec Superior Court issued earlier today a final order approving the previously announced statutory plan of arrangement u...
MONTREAL, April 09, 2019 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA) ("Clementia" or the "Corporation") is pleased to announce that its shareholders have approved the previously announced statutory plan of arrangement under the Canada Business Corporations Act ...